BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 29135516)

  • 1. International Endocervical Adenocarcinoma Criteria and Classification (IECC): A New Pathogenetic Classification for Invasive Adenocarcinomas of the Endocervix.
    Stolnicu S; Barsan I; Hoang L; Patel P; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Pike MC; Oliva E; Park KJ; Soslow RA
    Am J Surg Pathol; 2018 Feb; 42(2):214-226. PubMed ID: 29135516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Algorithmic Proposal Based on Comprehensive Immunohistochemical Evaluation of 297 Invasive Endocervical Adenocarcinomas.
    Stolnicu S; Barsan I; Hoang L; Patel P; Chiriboga L; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Pike MC; Oliva E; Park KJ; Soslow RA
    Am J Surg Pathol; 2018 Aug; 42(8):989-1000. PubMed ID: 29851704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Outcomes of HPV-associated and Unassociated Endocervical Adenocarcinomas Categorized by the International Endocervical Adenocarcinoma Criteria and Classification (IECC).
    Stolnicu S; Hoang L; Chiu D; Hanko-Bauer O; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Oliva E; Park KJ; Abu-Rustum NR; Soslow RA
    Am J Surg Pathol; 2019 Apr; 43(4):466-474. PubMed ID: 30720532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in invasive adenocarcinoma of the cervix.
    Stolnicu S; Hoang L; Soslow RA
    Virchows Arch; 2019 Nov; 475(5):537-549. PubMed ID: 31209635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International Endocervical Adenocarcinoma Criteria and Classification (IECC): correlation with adverse clinicopathological features and patient outcome.
    Hodgson A; Olkhov-Mitsel E; Howitt BE; Nucci MR; Parra-Herran C
    J Clin Pathol; 2019 May; 72(5):347-353. PubMed ID: 30679193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Endocervical adenocarcinomas classified by International Endocervical Adenocarcinoma Criteria and Classification: a clinicopathological and prognostic analysis of 286 cases].
    Lyu BJ; Shi HY; Shao Y; Liu Q; Lyu WG
    Zhonghua Bing Li Xue Za Zhi; 2021 Sep; 50(9):1014-1019. PubMed ID: 34496491
    [No Abstract]   [Full Text] [Related]  

  • 7. [Assessment of the diagnostic value and prognosis of different detection markers in endocervical adenocarcinoma].
    Zhang CN; Liu XY; Li Q; Song YZ; Liu B; Yin J; Yang JH; Zhong L; Sun L; Zhang X; Chen W
    Zhonghua Zhong Liu Za Zhi; 2023 May; 45(5):402-409. PubMed ID: 37188625
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of human papillomavirus (HPV) prediction using the International Endocervical Adenocarcinoma Criteria and Classification system, compared to p16 immunohistochemistry and HPV RNA in-situ hybridization.
    Ren H; Pors J; Chow C; Ta M; Stolnicu S; Soslow R; Huntsman D; Hoang L
    J Pathol Transl Med; 2020 Nov; 54(6):480-488. PubMed ID: 32854489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocervical Adenocarcinoma With Morphologic Features of Both Usual and Gastric Types: Clinicopathologic and Immunohistochemical Analyses and High-risk HPV Detection by In Situ Hybridization.
    Wada T; Ohishi Y; Kaku T; Aman M; Imamura H; Yasutake N; Sonoda K; Kato K; Oda Y
    Am J Surg Pathol; 2017 May; 41(5):696-705. PubMed ID: 28296678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reproducibility of Morphologic Parameters of the International Endocervical Adenocarcinoma Criteria and Classification System and Correlation With Clinicopathologic Parameters: A Multi-Institutional Study.
    Bulutay P; Haberal N; Özen Ö; Erdem Ö; Zeren EH; Kulac İ; Taskiran Ç; Vatansever D; Ayhan A; Kapucuoğlu N
    Int J Gynecol Pathol; 2022 Sep; 41(5):447-458. PubMed ID: 34856570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International Endocervical Adenocarcinoma Criteria and Classification (IECC): An Independent Cohort With Clinical and Molecular Findings.
    Ren H; Almadani N; Pors J; Leung S; Ho J; Chow C; Ta M; Park KJ; Stolnicu S; Soslow R; Huntsman D; Gilks BC; Hoang L
    Int J Gynecol Pathol; 2021 Nov; 40(6):533-540. PubMed ID: 34612210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective study on incidence, diagnosis, and clinical outcome of gastric-type endocervical adenocarcinoma in a single institution.
    Radomska A; Lee D; Neufeld H; Korte N; Torlakovic E; Agrawal A; Chibbar R
    Diagn Pathol; 2021 Jul; 16(1):68. PubMed ID: 34332600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing Algorithms for the Diagnosis of Malignant Glandular Tumors of the Uterine Cervix Histotyped per the International Endocervical Adenocarcinoma Criteria and Classification (IECC) System.
    Duggan MA; Duan Q; Pfeiffer RM; Brett MA; Lee S; Abubakar M; Köbel M; Rodriguez M; Sar A
    Appl Immunohistochem Mol Morphol; 2022 Feb; 30(2):91-98. PubMed ID: 34799503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International Endocervical Adenocarcinoma Criteria and Classification: Validation and Interobserver Reproducibility.
    Hodgson A; Park KJ; Djordjevic B; Howitt BE; Nucci MR; Oliva E; Stolnicu S; Xu B; Soslow RA; Parra-Herran C
    Am J Surg Pathol; 2019 Jan; 43(1):75-83. PubMed ID: 29877920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming acidic coiled-coil protein-3: a novel marker for differential diagnosis and prognosis prediction in endocervical adenocarcinoma.
    Wen YL; Yan SM; Wei W; Yang X; Zhang SW; Yun JP; Liu LL; Luo RZ
    Mol Med; 2021 Jun; 27(1):60. PubMed ID: 34134633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A panel of 3 markers including p16, ProExC, or HPV ISH is optimal for distinguishing between primary endometrial and endocervical adenocarcinomas.
    Kong CS; Beck AH; Longacre TA
    Am J Surg Pathol; 2010 Jul; 34(7):915-26. PubMed ID: 20534993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometrial endometrioid adenocarcinoma of the uterine corpus involving the cervix: some cases probably represent independent primaries.
    Jiang L; Malpica A; Deavers MT; Guo M; Villa LL; Nuovo G; Merino MJ; Silva EG
    Int J Gynecol Pathol; 2010 Mar; 29(2):146-56. PubMed ID: 20173500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stromal invasion pattern identifies patients at lowest risk of lymph node metastasis in HPV-associated endocervical adenocarcinomas, but is irrelevant in adenocarcinomas unassociated with HPV.
    Stolnicu S; Barsan I; Hoang L; Patel P; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Oliva E; Park KJ; Abu-Rustum NR; Pike MC; Soslow RA
    Gynecol Oncol; 2018 Jul; 150(1):56-60. PubMed ID: 29859673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinction of endocervical and endometrial adenocarcinomas: immunohistochemical p16 expression correlated with human papillomavirus (HPV) DNA detection.
    Ansari-Lari MA; Staebler A; Zaino RJ; Shah KV; Ronnett BM
    Am J Surg Pathol; 2004 Feb; 28(2):160-7. PubMed ID: 15043304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical p16 overexpression and Rb loss correlate with high-risk human papillomavirus infection in endocervical adenocarcinomas.
    Yasutake N; Yamamoto H; Kuga R; Jiromaru R; Hongo T; Katayama Y; Sonoda K; Yahata H; Kato K; Oda Y
    Histopathology; 2024 Jun; 84(7):1178-1191. PubMed ID: 38445509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.